Search results
Arlington Asset Investment Corp. Reports Mixed Results Amidst Challenging Market Conditions
GuruFocus.com via Yahoo Finance· 6 months agoBook value per common share decreased by 3.5% to $6.41 from the previous quarter. GAAP net loss...
Prothena (PRTA) Skyrockets 88.7% in 12 Months: Here's Why
Zacks via Yahoo Finance· 8 months agoShares of late-stage clinical biotechnology Prothena PRTA surged 88.7% in a year against the...
Kenya's MyDawa aims to be an all-in-one health platform backed by $20 million funding
TechCrunch· 10 months agoKenyan e-health startup MyDawa has raised $20 million from private equity investor Alta Semper...
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoThank you for standing by, and welcome to the Acumen Pharmaceuticals second quarter 2022 update...
Japan’s health tech Ubie wants to fuel its US expansion with $19M Series C extension
TechCrunch· 1 year agoUbie, a Tokyo-based startup providing an AI-powered symptom checker app and hospital SaaS products,...
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoCognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript March 26, 2024 Cognition...
Omicron better at invading young noses than other variants; smell loss may predict memory issues
Reuters via Yahoo News· 2 years agoThe Omicron variant may be more efficient at infecting children through the nose than previous...
Africa-focused funds find their feet amid a downturn
TechCrunch· 3 months agoIn the midst of a funding downtime last year, and with conditions getting tougher for fund managers raising capital as backers (limited partners)...
What stocks do your lawmakers trade? See investments by NC members of Congress
Raleigh News and Observer via AOL· 1 year agoDoes your representative own any stocks? Are they trading on information they obtained while...
Q2 2023 Cognition Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 9 months agoParticipants Anthony O. Caggiano; Chief Medical Officer and Head of R&D; Cognition Therapeutics, Inc. Daniel Kontoh-Boateng John Brendan Doyle; CFO; Cognition Therapeutics, Inc. Lisa Ricciardi ...
